Miss Hang Su

  1. Erthygl › Ymchwil › Adolygwyd gan gymheiriaid
  2. Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study

    Shi, F., He, Z., Wang, L., Su, H. & Han, S., 18 Hyd 2022, Yn: Frontiers in Pharmacology. 13

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  3. Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China

    Shi, F., He, Z., Su, H., Wang, L. & Han, S., 16 Tach 2022, Yn: Frontiers in Pharmacology. 13

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid